Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Venetoclax Combined With Azacitidine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 0 results

Large-scale testing (Phase 3)UnknownNCT05264883
What this trial is testing

Venetoclax+HMA+Aclarubicin Versus Venetoclax+HMA in Treatment-Naive Elderly Patients With AML

Who this might be right for
Acute Myeloid Leukemia
The First Affiliated Hospital with Nanjing Medical University 170
Testing effectiveness (Phase 2)Looking for participantsNCT05074355
What this trial is testing

Study of Venetoclax and Azacitidine in Advanced BCR-ABL Negative Myeloproliferative Neoplasms

Who this might be right for
Myeloproliferative Neoplasm
University Health Network, Toronto 40
Testing effectiveness (Phase 2)Ended earlyNCT06150040
What this trial is testing

Acute Myeloid Leukemia Treated With With NETrin Abs in Combination With [AZACITIDINE + VENETOCLAX]

Who this might be right for
Acute Myeloid Leukemia Refractory
Centre Leon Berard 1
Large-scale testing (Phase 3)Ended earlyNCT04778397
What this trial is testing

Study of Magrolimab in Combination With Azacitidine Versus Physician's Choice of Venetoclax in Combination With Azacitidine or Intensive Chemotherapy in Patients With TP53 Mutant Acute Myeloid Leukemia That Have Not Been Treated

Who this might be right for
Acute Myeloid Leukemia
Gilead Sciences 258
Large-scale testing (Phase 3)Not Yet RecruitingNCT07623187
What this trial is testing

Assess How Well the Study Medicine IPN60340 Works in Combination With Azacitidine and Venetoclax, Compared to Placebo in Combination With Azacitidine and Venetoclax, in Participants With Newly Diagnosed Acute Myeloid Leukemia Who Cannot Receive Intensive Chemotherapy

Who this might be right for
Acute Myeloid Leukaemia (AML)Acute Myeloid Leukaemia
Ipsen 540
Testing effectiveness (Phase 2)Active Not RecruitingNCT05768711
What this trial is testing

Azacitidine Combined With Venetoclax in Patients With Higher-risk Chronic Myelomonocytic Leukemia (AVENHIR)

Who this might be right for
Chronic Myeloid Leukemia
Groupe Francophone des Myelodysplasies 44
Testing effectiveness (Phase 2)WithdrawnNCT06770257
What this trial is testing

Daunorubicin, Cytarabine Liposomes Plus Venetoclax vs Azacitidine Plus Venetoclax in AML Patients Unfit for Intensive Chemotherapy

Who this might be right for
Leukemia, Myeloid, Acute
Institute of Hematology & Blood Diseases Hospital, China
Early research (Phase 1)Study completedNCT02966782
What this trial is testing

A Study Evaluating Venetoclax Alone and in Combination With Azacitidine in Participants With Relapsed/Refractory Myelodysplastic Syndromes (MDS)

Who this might be right for
Myelodysplastic Syndromes (MDS)
AbbVie 70
Testing effectiveness (Phase 2)Ended earlyNCT05361057
What this trial is testing

Efficacy of Venetoclax Based Regimen in Prevention Relapse of Consecutive MRD Positive AML Patients

Who this might be right for
Acute Myeloid LeukemiaMeasurable Disease
Institute of Hematology & Blood Diseases Hospital, China 20
Large-scale testing (Phase 3)Study completedNCT06073730
What this trial is testing

Comparison of the Efficacy and Safety of Venetoclax in Combination With 3 Days Decitabine (DEC3-VEN) vs. Venetoclax in Combination With Azacitidine (VIALE-A) in the Treatment of Elderly Patients or Unfit, New-diagnosis Acute Myeloid Leukemia Patients

Who this might be right for
Elderly AML PatientsUnfit, New-diagnosis AMLAcute Myeloid Leukemia+2 more
The Second Affiliated Hospital of Kunming Medical University 154
Testing effectiveness (Phase 2)Active Not RecruitingNCT04128501
What this trial is testing

Venetoclax and Azacitidine for the Treatment of Acute Myeloid Leukemia in the Post-Transplant Setting

Who this might be right for
Acute Bilineal LeukemiaAcute Biphenotypic LeukemiaAcute Myeloid Leukemia+3 more
M.D. Anderson Cancer Center 100
Early research (Phase 1)Ended earlyNCT06158100
What this trial is testing

Venetoclax in Combination With Azacitidine (VEN/AZA) Followed by Donor Lymphocyte Infusion (DLI) for Patients With Very High-Risk Acute Myeloid Leukemia (AML) Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)

Who this might be right for
Acute Myeloid Leukemia
Antonio M Jimenez Jimenez 2